Zacks Research Issues Positive Forecast for Plexus Earnings

Plexus Corp. (NASDAQ:PLXS) – Investment analysts at Zacks Research raised their Q2 2026 earnings estimates for Plexus in a research note issued to investors on Wednesday, February 11th. Zacks Research analyst Team now expects that the technology company will post earnings per share of $1.62 for the quarter, up from their prior estimate of $1.51. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q3 2026 earnings at $1.72 EPS, Q4 2026 earnings at $1.79 EPS, FY2026 earnings at $6.64 EPS, Q1 2027 earnings at $1.71 EPS, Q3 2027 earnings at $1.87 EPS, Q4 2027 earnings at $2.06 EPS, FY2027 earnings at $7.34 EPS, Q1 2028 earnings at $1.85 EPS and FY2028 earnings at $8.06 EPS.

Several other brokerages have also recently commented on PLXS. Williams Trading set a $195.00 price target on Plexus in a research report on Wednesday, January 28th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a report on Friday, October 24th. Stifel Nicolaus upped their price target on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research note on Friday, January 30th. Benchmark increased their price target on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Finally, Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $189.20.

Plexus Stock Performance

Shares of NASDAQ:PLXS opened at $201.28 on Monday. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $211.84. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. The business’s fifty day moving average price is $171.66 and its two-hundred day moving average price is $151.16. The stock has a market capitalization of $5.39 billion, a price-to-earnings ratio of 31.30 and a beta of 0.81.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the company posted $1.73 earnings per share. Plexus’s quarterly revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.

Insider Buying and Selling

In related news, CFO Patrick John Jermain sold 3,587 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $204.09, for a total value of $732,070.83. Following the completion of the sale, the chief financial officer directly owned 16,882 shares in the company, valued at $3,445,447.38. The trade was a 17.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Michael J. Running sold 926 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $204.92, for a total value of $189,755.92. Following the transaction, the insider owned 1,295 shares in the company, valued at $265,371.40. The trade was a 41.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 30,951 shares of company stock worth $6,077,670 in the last 90 days. 1.78% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Plexus

A number of large investors have recently bought and sold shares of PLXS. Vanguard Group Inc. boosted its position in Plexus by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock worth $533,016,000 after buying an additional 22,374 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Plexus by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock worth $201,903,000 after buying an additional 7,051 shares during the period. American Century Companies Inc. grew its position in shares of Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after buying an additional 338,119 shares during the last quarter. State Street Corp raised its position in shares of Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock worth $143,361,000 after acquiring an additional 24,115 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in shares of Plexus by 4.0% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company’s stock worth $132,434,000 after acquiring an additional 35,237 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

More Plexus News

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks raised several near‑term quarterly estimates (notably Q2 2026 to $1.62 from $1.51, Q3 2026 to $1.72 from $1.65 and Q4 2026 to $1.79 from $1.70), signaling stronger expected revenue/earnings cadence for 2026. Zacks raises near-term estimates for Plexus (MarketBeat)
• Positive Sentiment: Zacks also lifted FY2026–FY2028 forecasts (FY2026 to $6.64 from $6.38; FY2027 to $7.34 from $7.08; FY2028 to $8.06 from $7.86), increasing the multi‑year earnings trajectory investors use for valuation and target setting.
• Positive Sentiment: Zacks reiterated a “Strong‑Buy” on PLXS, which can attract momentum‑driven flows and analyst‑led buying given the upgraded outlook.
• Neutral Sentiment: Fundamental context: Plexus recently posted a slight EPS beat and set Q2 2026 guidance, but the shares trade at a premium (P/E ~31x) and volume today is below average — upside depends on continued execution and revenue growth translating to margin expansion.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.